Fulgent Genetics Reports Fourth Quarter and Full Year 2016 Financial Results
Feb 27, 2017 21:05 pm UTC| Business
Fourth Quarter Revenue doubles year over year to $5.9 Million and reaches $18.3 Million for the Full Year of 2016Fourth Quarter 2016 GAAP Income totals $0.8 Million, or $0.05 per ShareFourth Quarter 2016 Non-GAAP Income...
Integer Holdings Corporation Reports Results for Fourth Quarter and Full Year 2016
Feb 27, 2017 21:05 pm UTC| Business
~ Provides Business Outlook for Full Year 2017 ~ Note: A webcast of Integer’s conference call and accompanying presentation slides will be available at 5:00 p.m. EST today athttp://investor.integer.net. FRISCO,...
Kona Grill Reports Fourth Quarter 2016 Results
Feb 27, 2017 21:05 pm UTC| Business
SCOTTSDALE, Ariz., Feb. 27, 2017 -- Kona Grill, Inc. (NASDAQ:KONA), an American grill and sushi bar, reported financial results for the fourth quarter and year ended December 31, 2016. The Company also initiated 2017...
Gary Haire to Join Integer as Executive Vice President and Chief Financial Officer
Feb 27, 2017 21:05 pm UTC| Business
FRISCO, Texas, Feb. 27, 2017 -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource (MDO) manufacturer, today announced that Gary Haire is joining the Company and will be appointed Executive...
Feb 27, 2017 21:02 pm UTC| Business
MINNEAPOLIS, Feb. 27, 2017 -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company that develops and provides innovative medical devices for the treatment of chronic diseases...
Editas Medicine to Present at Investor Conferences in March
Feb 27, 2017 21:01 pm UTC| Business
CAMBRIDGE, Mass., Feb. 27, 2017 -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that management will participate in two upcoming investor conferences in March. Details of the...
Feb 27, 2017 21:01 pm UTC| Business
SAN DIEGO, Feb. 27, 2017 -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, will release its fourth quarter...